CoChat

High Concurrent Use of Sulfonylureas and Antimicrobials With Drug Interactions Causing Hypoglycemia

Pilla, Scott J., Pitts, Samantha I., Maruthur, Nisa M. · 2022 · Journal of Patient Safety

The DOI matches its Crossref record; 56 of the 58 references it cites were found in a registry or an index.

Abstract

Objectives: Sulfonylureas, the second most common oral diabetes treatment, have interactions with antimicrobials that substantially increase the risk of hypoglycemia. The objectives of this study are to quantify the concurrent use of sulfonylureas and interacting antimicrobial in U.S. ambulatory care and to examine whether interacting antimicrobials are used for an appropriate indication. Methods: We analyzed the 2006–2016 National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey, annual probability samples of visits to U.S. office-based physicians. We determined nationally representative estimates of visits for adults with concurrent use of sulfonylureas and 7 antimicrobials with established interactions. We examined whether visit diagnoses included appropriate indications for antibiotics according to national guidelines. Results: There were 2.5 million visits per year (95% confidence interval [CI] 2.2–2.9) in which sulfonylureas were used with systemic antimicrobials, of which 1 million (95% CI, 0.8–1.2) or 38.0% (95% CI, 32.3%–44.0%) were interacting antimicrobials. Sulfonylurea users had similar odds of interacting antimicrobial use as patients using diabetes medications without antimicrobial interactions (adjusted odds ratio, 1.07; 95% CI, 0.82–1.40). The most common interacting antimicrobials used with sulfonylureas were fluoroquinolones, accounting for 59.9% (95% CI, 50.7%–68.2%) of antimicrobials, and sulfamethoxazole-trimethoprim, accounting for 21.1% (95% CI, 14.8%–29.2%). There was no appropriate antibiotic indication in 69.7% (95% CI, 55.2%–81.1) of visits with interacting antibiotic use. Conclusions: Sulfonylureas and antimicrobials with potentially hazardous interactions are frequently used together. To reduce resultant hypoglycemic events, there is a need for interventions to increase physician awareness and promote antibiotic stewardship.

Overview

Integrity signals

Registry

Crossref · 10.1097/pts.0000000000000739

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 56 references

Research works printed but not linked: 1

  1. 2008, Prescribers’ knowledge of and sources of information for potential drug-drug interactions: a postal survey of US prescribers, Drug Saf, 31, 525

Cited by

See all 12

Metadata

Authors
Pilla, S. J., Pitts, S. I., & Maruthur, N. M.
Affiliations
Johns Hopkins University (US)
Corresponding author
  • Pilla, Scott J.
  • Pitts, Samantha I.
  • Maruthur, Nisa M.
Venue
Journal of Patient Safety
Published
2020-06-22
Volume
18
Issue
1
Pages
e217-e224
ISSN
  • 1549-8417 (ISSN-L)
  • 1549-8425
OpenAlex
W3036878951
Cited by
12
References
58
Citations by year
2026: 1 · 2025: 6 · 2024: 3 · 2023: 2
FWCI
0.26
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Patient Safety (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (U01DK057149)
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
  • Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
Keywords
sulfonylureas, antimicrobial agents, drug interactions, hypoglycemia, fluoroquinolones, trimethoprim-sulfamethoxazole, rational antibiotic use, antibiotic stewardship, antidiabetic drugs, outpatient care, prescribing patterns
MeSH terms
Adult, Anti-Infective Agents, Drug Interactions, Humans, Hypoglycemia, Hypoglycemic Agents, Sulfonylurea Compounds, United States

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: High Concurrent Use of Sulfonylureas and Antimicrobials With Drug Interactions Causing Hypoglycemia. https://app.cochat.ai/papers/10.1097/pts.0000000000000739
The paper
Pilla, S. J., Pitts, S. I., & Maruthur, N. M. (2022). High Concurrent Use of Sulfonylureas and Antimicrobials With Drug Interactions Causing Hypoglycemia. Journal of Patient Safety. https://doi.org/10.1097/pts.0000000000000739

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.